Abstract
Risk variants of the apolipoprotein-L1 (APOL1) gene are associated with severe kidney disease, putting homozygous carriers at risk. Since APOL1 lacks orthologs in all major model organisms, a wide range of mechanisms frequently in conflict have been described for APOL1-associated nephropathies. The genetic toolkit in Drosophila allows unique in vivo insights into disrupted cellular homeostasis. To perform a mechanistic analysis, we expressed human APOL1 control and gain-of-function kidney risk variants in the podocyte-like garland cells of Drosophila nephrocytes and a wing precursor tissue. Expression of APOL1 risk variants was found to elevate endocytic function of garland cell nephrocytes that simultaneously showed early signs of cell death. Wild-type APOL1 had a significantly milder effect, while a control transgene with deletion of the short BH3 domain showed no overt phenotype. Nephrocyte endo-lysosomal function and slit diaphragm architecture remained unaffected by APOL1 risk variants, but endoplasmic reticulum (ER) swelling, chaperone induction, and expression of the reporter Xbp1-EGFP suggested an ER stress response. Pharmacological inhibition of ER stress diminished APOL1-mediated cell death and direct ER stress induction enhanced nephrocyte endocytic function similar to expression of APOL1 risk variants. We confirmed APOL1-dependent ER stress in the Drosophila wing precursor where silencing the IRE1-dependent branch of ER stress signaling by inhibition with Xbp1-RNAi abrogated cell death, representing the first rescue of APOL1-associated cytotoxicity in vivo. Thus, we uncovered ER stress as an essential consequence of APOL1 risk variant expression in vivo in Drosophila, suggesting a central role of this pathway in the pathogenesis of APOL1-associated nephropathies.
Keywords: APOL1, Drosophila, endoplasmic reticulum stress, focal segmental glomerular sclerosis, nephrocyte, podocyte
African ancestry is associated with a significantly higher prevalence of end-stage kidney disease.1 Genetic studies identified 2 risk variants (termed G1 and G2) within the gene apolipoprotein-L1 (APOL1) that account for ≈70% of the excess risk.2-7 The risk variants are exceedingly common as heterozygous presence confers protection against sleeping sickness.8,9 In the homozygous state, the risk variants are associated with debilitating glomerular disease,10 such as global or focal segmental glomerular sclerosis10 and HIV-associated or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–associated collapsing focal segmental glomerular sclerosis.11 Homozygous carriers, estimated at >70 million worldwide,7 carry a lifetime risk for APOL1-associated kidney disease of ~15%.10 Targeted therapies are unavailable, and the pathogenesis of APOL1-associated nephropathies remains a conundrum. The renal pathogenesis appears independent from circulating APOL112,13 but linked to the gene’s intracellular function. Kidneys from donors carrying the APOL1 risk variants showed reduced allograft survival in wild-type recipients,14 despite the presence of wild-type APOL1 in the recipient’s circulation. However, because orthologs are restricted to higher primates, the cell-autonomous function of APOL1 is poorly understood. APOL1 G1 and G2 variants are considered hypermorphic alleles because APOL1 is dispensable in most mammals and human subjects carrying APOL1 null alleles showed no renal anomalies.15 Loss-of-function hypotheses were proposed,16-18 but the currently prevalent hypothesis involves a dose-dependent deleteriousness of APOL1 that is subject to modifiers,19 requiring second hits. The latter include environmental factors20 and inflammatory processes, because interferons and toll-like receptor agonists elevate expression of APOL1.21 Supporting the gain-of-function hypothesis, APOL1 risk alleles entail cytotoxicity. Necrosis, pyroptosis, apoptosis, and autophagic cell death have been described on expression of APOL1 risk variants.22-27 Mice with transgenic expression of human APOL1 recapitulated aspects of human disease, such as proteinuria and podocyte depletion.27-29 The proposed mechanisms of APOL1-associated renal disease include autophagic flux,26,27 impaired endocytosis,30-32 mitochondrial dysfunction,33,34 downregulation of miR193a,18 coactivation of integrins with soluble urokinase plasminogen activator receptor (suPAR),35 Na+/Ca2+-influx,36 activation of protein kinases,22,37 and endoplasmic reticulum (ER) stress.38 The plethora of reported abnormalities makes it difficult to identify the key signaling pathways. Transgenic expression of APOL1 in Drosophila pericardial nephrocytes30,31 resulted in an initial increase of endocytic nephrocyte function and nephrocyte death on prolonged expression in adult flies. However, the underlying mechanisms remained unclear. Herein, we employed transgenic expression of APOL1 variants in Drosophila larvae and performed a mechanistic analysis using garland cell nephrocytes and wing imaginal discs. We identified ER stress induction as the essential cause of APOL1-dependent cytotoxicity in Drosophila.
METHODS
Fly strains and husbandry
Flies were reared on standard food at room temperature, 18 °C, 25 °C, or 29 °C, as indicated. Overexpression and transgenic RNA interference (RNAi) studies were performed using the upstream activating sequence (UAS)/GAL4 system. Fly stocks used in this study are described in Supplementary Table S1.
Transgenesis of human APOL1
To generate APOL1-expressing transgenic flies, we cloned human APOL1 full-length cDNA (GE Dharmacon; GenBank: BC112943.1) into pUASg-attB (from K. Basler). The DNA was injected into flies expressing phiC31 integrase under vasa promoter with an attP landing site (86F8) by BestGene. Primer sequences see Supplementary Table S2. Hemagglutinin (HA) tags are present in all APOL1 transgenes unless otherwise indicated. New lines generated for this study are G0-APOL1-no tag, G0-APOL1, G2-APOL1-no tag, G2-APOL1, G1-APOL1, ΔBH3-G2-APOL1, and ΔBH3-G2-APOL1-no tag. Genetic combinations were achieved by standard crosses.
Fluorescent tracer uptake
Fluorescent tracer uptake in nephrocytes to evaluate nephrocyte function was performed as previously described.39 Briefly, nephrocytes were dissected in phosphate-buffered saline (PBS) and incubated with fluorescein isothiocyanate (FITC)–albumin (Sigma) or Texas Red–avidin (Thermofisher) for 30 seconds. After a fixation step of 5 minutes in 8% paraformaldehyde, cells were rinsed in PBS and exposed to Hoechst 33342 (1:1000) for 20 seconds and mounted in ROTI-Mount (Carl Roth). Cells were imaged using a Zeiss LSM 880 laser-scanning microscope. Quantitation of fluorescent tracer uptake was performed with ImageJ software. The results are expressed as a ratio to a control experiment with flies carrying the (heterozygous) GAL4 transgene but no UAS that was done in parallel.
For the fluorescent double tracer uptake to study processing of endocytic cargo, nephrocytes were dissected in Schneider’s medium and incubated with FITC-albumin for 30 seconds. Washing steps with cold PBS were followed by a 45-minute chase period in Schneider’s medium at 25 °C and Texas Red–albumin was applied and incubated for 3 minutes. After fixation for 5 minutes in 8% paraformaldehyde, cells were rinsed in PBS and exposed to Hoechst 33342 (1:1000) for 20 seconds and mounted in ROTI-Mount (Carl Roth). Image quantitation was performed using ImageJ software.
LysoTracker assay
For Lysotracker labeling, larvae were dissected, incubated in PBS containing 0.25 μM Lysotracker (LysoTracker Red DND-99; Thermofisher; L7528) for 5 minutes before immediate live cell imaging on a Zeiss LSM 880 laser-scanning microscope. Image processing was done by ImageJ and GIMP software.
Immunoblotting of Drosophila tissue
For immunoblotting from Drosophila tissue, we dissected 30 to 40 wing imaginal discs per genotype from third instar larvae expressing APOL1 variants for 24 hours using ptc-GAL4; GAL80ts. The explanted tissue was incubated for 15 minutes in ice-cold immunoprecipitation lysis buffer containing protease inhibitor (Merck/Roche). After sonication, samples were centrifuged for 15 minutes at 14,000 rpm and loaded onto a 10% sodium dodecylsulfate–polyacrylamide gel. Protein was transferred to polyvinylidene difluoride membranes (Millipore/Thermofisher). APOL1-HA transgene expression was detected using rat anti-HA (1186742300; Merck/Roche); mouse anti-tubulin (E7; DSHB) served as loading control.
TUNEL assay and immunofluorescence
For immunofluorescence, nephrocytes or wing imaginal discs were dissected, fixed for 20 minutes in 4% paraformaldehyde, blocked in 5% albumin for 1 hour, incubated in primary antibodies overnight, and in Alexa fluorophore–conjugated secondary antibodies (Invitrogen) for 2 hours before mounting in ROTI-Mount (Carl Roth). Primary antibodies are described in Supplementary Table S3. For terminal deoxynucleotidyl transferase–mediated dUTP nick end-labeling (TUNEL), larvae were dissected, fixed in 4% paraformaldehyde for 15 minutes, and stained according to the manufacturer’s instructions (In situ Cell Death Detection Kit, Fluorescein; Roche catalog number 11684795910). For Texas Red–avidin colabeling, tracer uptake was performed before the fixation step, followed by TUNEL. For imaging, a Zeiss LSM 880 laser-scanning microscope was used. Image processing was done by ImageJ and GIMP software.
Drosophila drug feeding
For short-term pharmacologic ER stress inhibition, late second instar larvae were raised in liquid food (H2O with 5% sucrose, 10% yeast extract, and 0.5% propionic acid) containing 4 mM 4-phenylbutyric acid (4-PBA) as an ER stress inhibitor for 24 hours at 25 °C followed by dissection and staining according to standard procedure. For prolonged ER stress inhibition, early second instar larvae were raised on grape juice plates (H2O with 25% grape juice, 2.15% agar, 1.25% sugar, and 0.2% nipagin) with yeast containing 4 mM 4-PBA for 48 hours at 29 °C followed by dissection of the adult nephrocytes and staining after eclosure. For short-term ER stress induction, early third instar larvae were exposed to tunicamycin, 10 μg/ml, in liquid food for 5 hours at 25 °C followed by dissection and staining.
Electron microscopy
For transmission electron microscopy, nephrocytes were dissected and fixed in 4% paraformaldehyde and 0.5% glutaraldehyde in 0.1 M cacodylate buffer, embedded in 2% low melting agarose (Invitrogen), postfixed in 1% osmium tetroxide, and incubated in 1% uranyl acetate. Dehydration was performed using ethanol. After embedding in Durcupan resin, ultrathin sections were cut using a UC7 Ultramicrotome (Leica). Grids were imaged using a Leo 912 transmission electron microscope (Zeiss).
Plasmids
APOL1 full-length cDNA was subcloned after polymerase chain reaction (GE Dharmacon; GenBank: BC112943.1). This clone carries 3 single-nucleotide polymorphisms (E150K, M228I, and R255K) that represent one of the most common haplotypes, thus deviating from the reference that actually is a minor APOL1 haplotype. We did not revert the clone to E150, which predominates in Africa. This might blunt risk variant toxicity in our transgenes.40 The mutation reflecting G2-APOL1 was generated using Quik change II XL site-directed mutagenesis kit (Agilent Technologies). G1-APOL1 and other modifications were generated by polymerase chain reaction followed by Gibson Assembly (New England Biolabs) and LR reactions (LR clonase II Enzyme Mix; Thermofisher). Primers are shown in Supplementary Table S2.
Statistical analysis
Paired t test was used to determine the statistical significance between 2 interventions. Analysis of variance followed by Dunnett’s correction (unless otherwise indicated) was used for multiple comparisons (GraphPad Prism software). Asterisks indicate significance as follows: *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. A statistically significant difference was defined as P < 0.05. Error bars indicate SD.
RESULTS
Expression of human APOL1 risk variants increases garland cell nephrocyte function and induces cell death indicated by TUNEL positivity
Nephrocytes in Drosophila form slit diphragms across membrane invaginations representing a podocyte model for genetic kidney diseases.39,41 Transgenesis of APOL1 risk variants in adult pericardial nephrocytes was shown to result in a short-term increase of nephrocyte function but functional decline and cell death with prolonged expression.30,31 To explore the function of APOL1, we generated transgenic Drosophila lines expressing wild-type G0-APOL1 and the risk variants G1 (p.S342G and p.I384M) and G2 (del: N388/Y389), each carrying a single-copy C-terminal influenza HA tag (Figure 1a; HA tags are present in all APOL1 transgenes unless otherwise indicated). An identical landing site (ZH-86Fb) using phiC31 integrase was chosen for all transgenes to ensure equal expression, which was further confirmed by immunoblotting (Supplementary Figure 1A). A G2-APOL1 variant that lacks 9 amino acids (del: L158-Q166) in the BCL2 homology domain 326 (ΔBH3-G2), which is part of the protein’s pore forming domain, served as control protein (Figure 1a). Because expression of our transgenes using prospero-GAL4 and Dorothy-GAL4 resulted in early lethality (data not shown), we employed Hand-GAL4 or dKlf15-GAL4 that directed low-level expression in nephrocytes, allowing eclosure of phenotypically normal adults for all transgenes. We studied garland cell nephrocyte function in third instar larvae based on FITC-albumin endocytosis39 and confirmed a significantly increased function for this nephrocyte subset on expression of APOL1 risk variants but not for the wild-type or the control protein (ΔBH3-G2-APOL1; Figure 1b and c; FITC-albumin/HA colabeling using dKlf15-GAL4; Supplementary Figure S1B). To study the impact of APOL1 on nephrocyte slit diaphragm formation, we stained the slit diaphragm proteins Sns (nephrin) and Kirre (NEPH1). We occasionally and variably observed few intracellular vesicles of the slit diaphragm proteins (Supplementary Figure S1C-G”), but otherwise noted no overt alteration of cellular slit diaphragm architecture for expression of all APOL1 variants (Figure 1d-h). Because APOL1 risk variant expression is known to entail cell death,2 we performed TUNEL that was previously employed to detect nephrocyte cell death.39,41 We observed a fraction of TUNEL-positive nephrocytes in third instar larvae that express APOL1 variants, predominantly on risk variant expression (Figure 1i-m). Quantification of TUNEL-positive nuclei confirmed a significantly higher positivity for the risk variants alone (Figure 1n). In larval nephrocytes, TUNEL-positive and TUNEL-negative nephrocytes exhibited similar uptake of Texas Red–avidin, suggesting these still functional nephrocytes showed an early stage of cell death (Figure 1o-r).
Staining adult nephrocytes expressing APOL1 variants under dKlf15-GAL4, we detected a significantly reduced number of nephrocytes exclusively for the risk variants compared with ΔBH3-G2-APOL1 (Supplementary Figure S2A-D‴; quantitation in Supplementary Figure S2E). Only few individual nephrocytes lacked transgene expression in ΔBH3-G2-APOL1 and G0-APOL1 but transgene expressing cells were mostly lacking for the risk variants (Supplementary Figure S2F). Taken together, we conclude that APOL1 risk variants cause cell death for a fraction of nephrocytes during the pupal stage, whereas few cells persisted after eclosion managing to escape cell death by downregulation of the transgene expression, which depends on the dKlf15-promoter.
Expression of human APOL1 risk variants does not result in defective endolysosomal processing
Defective endolysosomal acidification was described on transgenic APOL1 expression in adult Drosophila.30,31 To explore a role for acidification in our model, we performed lysotracker staining, but we observed no significant difference in lysotracker intensity between control and APOL1 variants (Figure 2a-e; quantitation in Figure 2f). Then, we stained the endosomal compartment markers Rab5 and Rab7, but the characteristic pattern of early/late endosomes remained unaltered by G2-APOL1 (Supplementary Figure S3A-B″). We costained G0-/G1-/G2/ΔBH3-G2-APOL1 in nephrocytes but observed colocalization neither with early (Supplementary Figure S3C-F″) nor late endosomal markers (Supplementary Figure S4A-D″), indicating absence of APOL1 variants from early/late endosomes. To study endolysosomal cargo processing directly, we applied endocytic tracers FITC-albumin and Texas Red–albumin ex vivo. After an initial tracer pulse of FITC-albumin, nephrocytes were chased for 45 minutes following a second pulse with Texas Red–albumin. Indicating endolysosomal processing, the tracer signals were sharply separated in control nephrocytes (Figure 2g). Inhibition of endolysosomal acidification by V-ATPase inhibitor bafilomycin resulted in slower processing and consecutively enhanced colocalization of both tracer fractions (Figure 2h). In contrast, G0/G2-APOL1 constructs did not interfere with cargo processing, and separation became even more apparent on expression of the risk variant G2-APOL1 (Figure 2i and j; quantitation in Figure 2k). Consequently, we found no evidence for an APOL1-mediated alteration of endolysosomal function.
APOL1 expression induces ER swelling in Drosophila nephrocytes
To explore alternative mechanisms, we performed electron microscopy that revealed normal slit diaphragms (Figure 3b-d; control in Figure 3a). Although defective autophagic flux has been reported with transgenic expression of APOL1 in mice,27 we observed no autophagosomes using electron microscopy. Instead, we noted mild swelling of the nephrocytes’ ER on expression of G0-APOL1 (Figure 3f; control in Figure 3e). ER swelling was significantly enhanced by expression of G1-APOL1 (Figure 3g), and strongest in G2-APOL1 (typical cell in Figure 3h, example for more severe swelling in Figure 3i, and quantitation in Figure 3j). This represents a strong indication of ER stress induction, through risk variant expression in particular. A similar connection was reported in immortalized podocytes.38
APOL1 variants localize to the ER and induce ER stress in Drosophila nephrocytes
To explore the role of the APOL1 variants, we determined their subcellular localization. Costaining HA-tag with the ER marker calnexin, we observed strong colocalization for all APOL1 variants in a near-identical staining pattern (Supplementary Figure S5B-E″; nonexpressing cell in Supplementary Figure S5A-A″). In almost all animals, the vast majority of APOL1-HA signal seemed to originate from the ER, whereas a minute fraction in the cytosol is possible. This is compatible with localization of APOL1 in human cells, where APOL1 protein was mainly detected in the ER,33,42-44 aside from other compartments,2 such as the plasma membrane.44 Of note, careful analyses,44 including most recent studies45 that differentiate between APOL1 and APOL2, indicate a luminal ER topology. Staining the HA-tagged G2-APOL1 with an anti-APOL1 antibody revealed an indistin-guishable staining pattern (Supplementary Figure S6A-A″), suggesting the HA staining reflects APOL1. We further generated several transgenic APOL1 variants lacking the C-terminal HA-tag, which equally colocalized with calnexin (Supplementary Figure S6B-D″). The HA-tag therefore does not affect the subcellular localization.
Because the subcellular localization of APOL1 variants seemed mostly restricted to the ER, causing ER swelling and cell death in risk variants, we hypothesized that APOL1 variants may induce an ER stress response in Drosophila nephrocytes. ER stress signaling prevents accumulation of unfolded protein by promoting ER homeostasis and survival through enhanced expression of chaperone proteins, whereas unmitigated ER stress activation induces cell death (schematic in Supplementary Figure S7). Upregulation of the ER marker and chaperone protein disulfide-isomerase (PDI) is an indicator of the ER stress activation.46 We stained PDI in nephrocytes expressing APOL1 control and risk variants and compared the fluorescence intensity. Confirming ER stress induction in nephrocytes, we observed a significantly enhanced intensity exclusively for the risk variants (Figure 4a-d″; quantitation in Figure 4e). Although cell death represents a canonical consequence of ER stress, we asked whether enhanced FITC-albumin endocytosis, previously only reported for Cubilin overexpression,47 also follows ER stress induction. We induced ER stress by feeding early third instar Drosophila larvae for 5 hours with liquid food containing tunicamycin (10 μg/ml), which significantly increased nephrocyte function based on the FITC-albumin assay (Figure 4f and g; quantitation in Figure 4h), whereas slit diaphragms remained undisturbed (Figure 4i-i″). Thus, ER stress induction phenocopies APOL1 risk variant expression.
APOL1 expression induces ER stress preceding cell death in Drosophila wing discs
To explore if the ER stress induction is specific for nephrocytes and confirm the effect in an epithelial model that enables recording of relative ER stress side by side within the same animal,46,48 we employed Drosophila wing precursor tissue. On expression of G0-APOL1 in a narrow strip within the wing imaginal disc using ptc-GAL4, we observed mild upregulation of PDI as an indication of ER stress (Figure 5a-a‴). Thus, APOL1-mediated ER stress is not limited to nephrocytes. Within the G0-APOL1 expression domain, induction of cell death was detected by staining of cleaved caspase-3 (Figure 5a-a‴), confirming that expression of wild-type APOL1 suffices to induce ER stress and cell death. However, overexpression of the renal risk variants G1-APOL1 (Figure 5b-b‴) and G2-APOL1 (Figure 5c-c‴) caused a markedly stronger upregulation of PDI and cell death, whereas the control transgene (ΔBH3-G2) had no effect (Figure 5d-d‴; quantitation for PDI/cleaved caspase-3 in Figure 5e and f). Studying adult wing phenotypes of G0-APOL1 and the renal risk variants was precluded by pupal lethality using ptc-GAL4, even with lower expression at 18 °C. In contrast, animals expressing ΔBH3-G2-APOL1 developed normally and formed regular wings (Supplementary Figure S8A and B). Expression with 1096-GAL4 that stimulated diffuse G0-/G2-APOL1 expression throughout the wing disc resulted in adult animals lacking wings (Supplementary Figure S8C; expression of G2-APOL1, not shown for G0-APOL1). To evaluate if ER stress precedes induction of cell death and occurs independently, we modified GAL4-dependent expression of APOL1 variants by GAL80ts, which blocks GAL4-dependent expression selectively at temperatures of <29 °C. We raised larvae at 25 °C and induced APOL1 variant expression acutely through a temperature shift to 29 °C. ΔBH3-G2-APOL1, G0-APOL1, and G2-APOL1 each were detectable after 24 hours, but only the renal risk variant G2-APOL1 but not ΔBH3-G2-APOL1 and G0-APOL1 resulted in significant upregulation of PDI (quantification for PDI/cleaved caspase-3 in Supplementary Figure S9A-E). Shortterm expression of any of the APOL1 variants lacked cell death. Significant cleaved caspase-3 became detectable after prolonged expression of G2-APOL1 for 48 hours (Supplementary Figure S10A-D). This confirms that APOL1-dependent activation of ER stress precedes cell death.
ER stress induction on G2-APOL1 causes IRE1-dependent ER stress
ER stress signaling is initiated by unfolded protein that buffers the chaperone binding-Ig protein (bip, CG4147). Bip dissociation from specific sensor proteins, such as inositol requiring enzyme 1 (IRE1), initiates the unfolded protein response49 (schematic in Supplementary Figure S7). To test activation of the IRE1-mediated branch of the ER stress signaling pathway directly, we generated flies expressing G2-APOL1 together with Xbp1–enhanced green fluorescent protein (EGFP).50 Transgenic reporter Xbp1-EGFP employs IRE1-mediated alternative splicing of Xbp1 that shifts the reading frame, and green fluorescent protein expression indicates activation of IRE1-dependent ER stress (Figure 6a). We focused exclusively on G2-APOL1 in the wing as G1-APOL1 showed extensive lethality with ptc-GAL4. EGFP was absent from the wing pouch under control conditions (Figure 6b) but became visible on induction of ER stress through silencing of Drosophila bip (Figure 6c). Similarly, expression of G2-APOL1 strongly induced the expression of Xbp1-EGFP, specifically indicating a G2-APOL1–dependent activation of the IRE1-mediated ER stress module (Figure 6d-d”). We further examined IRE1-mediated ER stress induction in nephrocytes and observed no significant increase of reporter activity for G0-APOL1 compared with control cells (Figure 6e-e”; control in Figure 6h). In contrast, expression of the risk variants G1- and G2-APOL1 significantly induced the Xb1-EGFP reporter that translocated to the nucleus (Figure 6f-g”; positive control in Figure 6i; quantitation in Figure 6j). This indicates that the APOL1 risk variants specifically activate IRE1-dependent ER stress.
Treatment with ER stress inhibitor 4-PBA attenuates APOL1-dependent cytotoxicity in Drosophila
To test if pharmacologic inhibition of ER stress decreases cell death in connection with APOL1 risk variants, we employed 4-PBA, a small molecule chemical chaperone and US Food and Drug Administration–approved drug. Late second instar G1- and G2-APOL1–expressing larvae were raised in liquid food that contained 4 mM 4-PBA or vehicle (H2O) for 24 hours, followed by TUNEL labeling. On 4-PBA treatment, we observed a significant reduction of TUNEL positivity for G1-APOL1 (Figure 7a and b; quantitation in Figure 7e), suggesting that cell death associated with G1 is a consequence of ER stress. For G2-APOL1 expression, that causes a more variable extent of TUNEL positivity; we similarly observed a trend for a reduced TUNEL positivity, but in a range that was statistically not significant (Figure 7c and d; quantitation in Figure 7e). To examine if nephrocyte survival during G2-APOL1 expression is improved by transient attenuation of ER stress, we studied nephrocyte numbers in adult animals with or without prolonged feeding with 4-PBA. Confirming improved survival, we observed a significantly increased number of nephrocytes after treatment with 4-PBA (Figure 7f-g”; quantitation of total number of adult nephrocytes in Figure 7h and number of G2-APOL1–expressing cells Figure 7i). Although 4-PBA strongly reduced G1-APOL1–dependent TUNEL positivity in larval nephrocytes (Figure 7e), this treatment was inefficient in rescuing adult nephrocyte numbers from the extensive toxicity of G1-APOL1 (data not shown). The transient 4-PBA exposure that inevitably is suspended for 4 days by lack of feeding during the pupal stage appears to convey insufficient acute ER stress attenuation for the more intense toxicity of G1-APOL1. To assess if G2-APOL1–dependent ER stress induction can be treated by pharmacologic inhibition in the wing, we again applied ER stress inhibitor 4-PBA short-term in larvae. On 4-PBA-treatment, we observed mild attenuation of PDI induction that was sufficient to significantly reduce caspase 3–dependent cell death in wing cells (Figure 7j-k‴; quantitation in Figure 7l). These data confirm that ER stress is essential for G2-APOL1–dependent toxicity and show a potential treatment strategy.
Silencing Xbp1 rescues APOL1-dependent cytotoxicity in the Drosophila wing disc
To test if the IRE1 module is critical for APOL1-mediated cytotoxicity, we inhibited this branch of ER stress concomitant with G2-APOL1 and G1-APOL1 expression in the wing disc. Coexpression of Xbp1-RNAi (Figure 8a-a‴/Figure 8c-c‴) but not control RNAi (green fluorescent protein; Figure 8b-b‴/Figure 8d-d‴) abrogated APOL1-dependent cleaved caspase-3 induction. This shows that IRE1-dependent ER stress induction is essential for cell death associated with either APOL1 risk variant. Although elevated expression of PDI remained detectable albeit at a lower level, this most likely indicates that APOL1 expression also triggers ER stress through another sensor protein, but silencing 1 of 3 unfolded protein response sensors seemed sufficient to abrogate cell death. The lesser extent of cell death associated with wild-type G0-APOL1 was equally blocked on Xbp1 silencing, indicating that wild-type and risk variants both induce Xbp1-dependent ER stress but at various degrees (Figure 8e-f‴; quantitations in Figure 8g and h). Coexpression of Xbp1-RNAi with ptc-GAL4 further reverted lethality of G1-/G2-APOL1. In contrast to control conditions, attenuation of ER stress allowed expression of APOL1 variants at 25 °C and eclosure of adults with phenotypically normal wings (Supplementary Figure S8D and E). Taken together, these data imply inhibition of IRE1-dependent ER stress as successful rescue for cytotoxicity of APOL1 transgene expression in vivo.
DISCUSSION
Herein, we explore the role of transgenic APOL1 renal risk variants in Drosophila. In the podocyte-like garland cell nephrocytes, we observed regular slit diaphragm formation, but gain of nephrocyte endocytic function and cell death specifically for the renal risk variants. In our model, we detected ER stress, indicated by pronounced ER swelling and chaperone upregulation. We specifically identified Xbp1-dependent ER stress induced by APOL1 risk variants. Cell death caused by APOL1 risk variants was blunted on pharmacologic attenuation of ER stress. Induction of ER stress by tunicamycin phenocopied APOL1-dependently enhanced nephrocyte function. We confirmed ER stress and cell death induction in the wing disc as an epithelial model that allows side-by-side comparison. Supporting a gain-of-function hypothesis, G0-APOL1 entailed milder ER stress and cytotoxicity, being exceeded by the risk variants. More important, Xbp1-RNAi abrogated cell death caused by G0-/G1-/G2-APOL1, confirming ER stress induction as the essential step for APOL1-dependent cytotoxicity in Drosophila.
Misfolding of APOL1 transgenes in Drosophila might cause ER stress. However, ER stress was also reported in human cells.38 Furthermore, we observed significant phenotypic differences between wild-type and risk variants; our control transgene, lacking merely 9 amino acids in the pore-forming domain, had no similar impact. Thus, misfolding seems unlikely, rather suggesting a specific mechanism, possibly related to ion transport. APOL1 acts as a pH-dependent cation channel,9,51 and most recent evidence reinforces the significance of this function.52,53 Therefore, ER stress is likely an effect that occurs downstream of cation conductance, and further work is needed to elucidate the mechanisms. Targeting ER stress may become a therapeutic strategy in the future. Because chronic ER stress inhibition appears to harm podocytes,54 a targeted approach will be required.
Defective endolysosomal acidification has previously been reported using Drosophila pericardial nephrocytes.30,31 In contrast to ER stress that precedes cell death, this defect appeared to be limited to late adult stages when nephrocyte numbers were reduced. It is difficult to extrapolate between the different models, but defective acidification could be the consequence, rather than the cause, of decreased cellular viability.
In conclusion, our findings define a critical role for ER stress in APOL1-mediated cytotoxicity in the Drosophila model.
Supplementary Material
Translational Statement.
Risk variants of the APOL1 gene put millions of homozygous carriers at risk for kidney disease with an unclear pathogenesis. We apply transgenic expression of the gain-of-function risk variants in comparison with APOL1 control variants in Drosophila podocyte-like nephrocytes and wing tissue. The Drosophila model facilitates a mechanistic analysis in vivo. Endoplasmic reticulum (ER) swelling and chaperone upregulation associated with the APOL1 risk variants indicated ER stress. Genetic and pharmacologic inhibition of ER stress rescued APOL1-dependent cytotoxicity. These findings uncover an essential role of ER stress signaling and thus open avenues for the development of therapeutic strategies for APOL1-associated nephropathies.
ACKNOWLEDGMENTS
We thank C. Meyer for excellent technical support and R. Nitschke, Life Imaging Centre, University of Freiburg, for help with confocal microscopy. We thank Severine Kayser for technical assistance with electron microscopy. We thank Giorgos Pyrowolakis, Anne Classen, Paul Hartley, Michael Köttgen, and Matias Simons for sharing transgenic Drosophila lines.
We thank the Developmental Studies Hybridoma Bank for antibodies. This research was supported by grants from the Deutsche Forschungsgemeinschaft to TH (HE 7456/3-1 and HE 7456/4-1) and project-ID 431984000–SFB 1453 (to TH and GW). LLK and JM were supported by the MOTI-VATE program of the Medical Faculty of the University of Freiburg. MC was supported by the China Scholarship Council. TH and KL acknowledge support from the Deutsche Gesellschaft für Innere Medizin.
Footnotes
DISCLOSURE
All the authors declared no competing interests.
REFERENCES
- 1.United States Renal Data System. 2016 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2016. [Google Scholar]
- 2.Friedman DJ, Pollak MR. APOL1 and kidney disease: from genetics to biology. Annu Rev Physiol. 2020;82:323–342. [DOI] [PubMed] [Google Scholar]
- 3.Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010;329:841–845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Tzur S, Rosset S, Shemer R, et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet. 2010;128:345–350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Friedman DJ, Pollak MR. Apolipoprotein L1 and kidney disease in African Americans. Trends Endocrinol Metab. 2016;27:204–215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Beckerman P, Susztak K. APOL1: the balance imposed by infection, selection, and kidney disease. Trends Mol Med. 2018;24:682–695. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kruzel-Davila E, Skorecki K. Dilemmas and challenges in apolipoprotein L1 nephropathy research. Curr Opin Nephrol Hypertens. 2019;28:77–86. [DOI] [PubMed] [Google Scholar]
- 8.Perez-Morga D, Vanhollebeke B, Paturiaux-Hanocq F, et al. Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science. 2005;309:469–472. [DOI] [PubMed] [Google Scholar]
- 9.Thomson R, Finkelstein A. Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: relevance to trypanosome lysis. Proc Natl Acad Sci U S A. 2015;112:2894–2899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Dummer PD, Limou S, Rosenberg AZ, et al. APOL1 kidney disease risk variants: an evolving landscape. Semin Nephrol. 2015;35:222–236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Velez JCQ, Caza T, Larsen CP. COVAN is the new HIVAN: the reemergence of collapsing glomerulopathy with COVID-19. Nat Rev Nephrol. 2020;16:565–567. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Bruggeman LA, O’Toole JF, Ross MD, et al. Plasma apolipoprotein L1 levels do not correlate with CKD. J Am Soc Nephrol. 2014;25:634–644. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Kozlitina J, Zhou H, Brown PN, et al. Plasma levels of risk-variant APOL1 do not associate with renal disease in a population-based cohort. J Am Soc Nephrol. 2016;27:3204–3219. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Reeves-Daniel AM, DePalma JA, Bleyer AJ, et al. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant. 2011;11:1025–1030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Johnstone DB, Shegokar V, Nihalani D, et al. APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis. PLoS One. 2012;7:e51546. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kotb AM, Simon O, Blumenthal A, et al. Knockdown of ApoL1 in zebrafish larvae affects the glomerular filtration barrier and the expression of nephrin. PLoS One. 2016;11:e0153768. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kumar V, Singhal PC. APOL1 and kidney cell function. Am J Physiol Renal Physiol. 2019;317:F463–F477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kumar V, Paliwal N, Ayasolla K, et al. Disruption of APOL1-miR193a axis induces disorganization of podocyte actin cytoskeleton. Sci Rep. 2019;9:3582. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Zhang JY, Wang M, Tian L, et al. UBD modifies APOL1-induced kidney disease risk. Proc Natl Acad Sci U S A. 2018;115:3446–3451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Langefeld CD, Comeau ME, Ng MCY, et al. Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions. Kidney Int. 2018;94:599–607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Zhaorigetu S, Wan G, Kaini R, et al. ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death. Autophagy. 2008;4:1079–1082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Olabisi OA, Zhang JY, VerPlank L, et al. APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases. Proc Natl Acad Sci U S A. 2016;113:830–837. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Cheng D, Weckerle A, Yu Y, et al. Biogenesis and cytotoxicity of APOL1 renal risk variant proteins in hepatocytes and hepatoma cells. J Lipid Res. 2015;56:1583–1593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Thomson R, Genovese G, Canon C, et al. Evolution of the primate trypanolytic factor APOL1. Proc Natl Acad Sci U S A. 2014;111:E2130–E2139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Lan X, Wen H, Lederman R, et al. Protein domains of APOL1 and its risk variants. Exp Mol Pathol. 2015;99:139–144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Wan G, Zhaorigetu S, Liu Z, et al. Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death. J Biol Chem. 2008;283:21540–21549. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Beckerman P, Bi-Karchin J, Park AS, et al. Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice. Nat Med. 2017;23:429–438. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Aghajan M, Booten SL, Althage M, et al. Antisense oligonucleotide treatment ameliorates IFN-gamma-induced proteinuria in APOL1-transgenic mice. JCI Insight. 2019;4:e126124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Bruggeman LA, Wu Z, Luo L, et al. APOL1-G0 or APOL1-G2 transgenic models develop preeclampsia but not kidney disease. J Am Soc Nephrol. 2016;27:3600–3610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Kruzel-Davila E, Shemer R, Ofir A, et al. APOL1-mediated cell injury involves disruption of conserved trafficking processes. J Am Soc Nephrol. 2017;28:1117–1130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Fu Y, Zhu JY, Richman A, et al. APOL1-G1 in nephrocytes induces hypertrophy and accelerates cell death. J Am Soc Nephrol. 2017;28:1106–1116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Madhavan SM, O’Toole JF, Konieczkowski M, et al. APOL1 variants change C-terminal conformational dynamics and binding to SNARE protein VAMP8. JCI Insight. 2017;2:e92581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Granado D, Muller D, Krausel V, et al. Intracellular APOL1 risk variants cause cytotoxicity accompanied by energy depletion. J Am Soc Nephrol. 2017;28:3227–3238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Ma L, Chou JW, Snipes JA, et al. APOL1 renal-risk variants induce mitochondrial dysfunction. J Am Soc Nephrol. 2017;28:1093–1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Hayek SS, Koh KH, Grams ME, et al. A tripartite complex of suPAR, APOL1 risk variants and alphavbeta3 integrin on podocytes mediates chronic kidney disease. Nat Med. 2017;23:945–953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Giovinazzo JA, Thomson RP, Khalizova N, et al. Apolipoprotein L-1 renal risk variants form active channels at the plasma membrane driving cytotoxicity. Elife. 2020;9:e51185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Okamoto K, Rausch JW, Wakashin H, et al. APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R. Commun Biol. 2018;1:188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Wen H, Kumar V, Lan X, et al. APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stress. Biosci Rep. 2018;38. BSR20171713. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Hermle T, Braun DA, Helmstadter M, et al. Modeling monogenic human nephrotic syndrome in the Drosophila garland cell nephrocyte. J Am Soc Nephrol. 2017;28:1521–1533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Lannon H, Shah SS, Dias L, et al. Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background. Kidney Int. 2019;96:1303–1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Weavers H, Prieto-Sanchez S, Grawe F, et al. The insect nephrocyte is a podocyte-like cell with a filtration slit diaphragm. Nature. 2009;457:322–326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Uzureau S, Lecordier L, Uzureau P, et al. APOL1 C-terminal variants may trigger kidney disease through interference with APOL3 control of actomyosin. Cell Rep. 2020;30:3821–3836.e3813. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Chun J, Zhang JY, Wilkins MS, et al. Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity. Proc Natl Acad Sci U S A. 2019;116:3712–3721. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Scales SJ, Gupta N, De Maziere AM, et al. Apolipoprotein L1-specific antibodies detect endogenous APOL1 inside the endoplasmic reticulum and on the plasma membrane of podocytes. J Am Soc Nephrol. 2020;31:2044–2064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Muller D, Schmitz J, Fischer K, et al. Evolution of renal-disease factor APOL1 results in cis and trans orientations at the endoplasmic reticulum that both show cytotoxic effects. Mol Biol Evol. 2021;38:4962–4976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Guida MC, Hermle T, Graham LA, et al. ATP6AP2 functions as a V-ATPase assembly factor in the endoplasmic reticulum. Mol Biol Cell. 2018;29:2156–2164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Zhang F, Zhao Y, Chao Y, et al. Cubilin and amnionless mediate protein reabsorption in Drosophila nephrocytes. J Am Soc Nephrol. 2013;24:209–216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Ryoo HD. Drosophila as a model for unfolded protein response research. BMB Rep. 2015;48:445–453. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Adams CJ, Kopp MC, Larburu N, et al. Structure and molecular mechanism of ER stress signaling by the unfolded protein response signal activator IRE1. Front Mol Biosci. 2019;6:11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Ryoo HD, Domingos PM, Kang MJ, et al. Unfolded protein response in a Drosophila model for retinal degeneration. EMBO J. 2007;26:242–252. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Bruno J, Pozzi N, Oliva J, et al. Apolipoprotein L1 confers pH-switchable ion permeability to phospholipid vesicles. J Biol Chem. 2017;292:18344–18353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Pant J, Giovinazzo JA, Tuka LS, et al. Apolipoproteins L1-6 share key cation channel-regulating residues but have different membrane insertion and ion conductance properties. J Biol Chem. 2021;297:100951. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Schaub C, Verdi J, Lee P, et al. Cation channel conductance and pH gating of the innate immunity factor APOL1 are governed by pore-lining residues within the C-terminal domain. J Biol Chem. 2020;295:13138–13149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Hassan H, Tian X, Inoue K, et al. Essential role of X-box binding protein-1 during endoplasmic reticulum stress in podocytes. J Am Soc Nephrol. 2016;27:1055–1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.